Drug Profile


Alternative Names: CN-100; Peon; Pyranoprofen; Soleton; ZC-102

Latest Information Update: 12 Nov 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nippon Chemiphar
  • Developer Nippon Chemiphar; Zeria
  • Class Antipyretics; Antirheumatics; Benzopyrans; Nonsteroidal anti-inflammatories; Propionic acids; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Inflammation; Musculoskeletal disorders; Pain; Rheumatic disorders
  • No development reported Respiratory tract disorders

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 02 Sep 2009 No development reported - Preregistration for Respiratory tract disorders in Japan (PO)
  • 14 Jun 2002 Preregistration for Respiratory tract disorders in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top